Prometheus Biosciences, Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$6.8M

Net Income/Loss (FY2022)

-$147.8M

Total Assets (FY2022)

$740.8M

Total Equity (FY2022)

$676.0M

Cash Flows from Operating Activities (FY2022)

-$123.3M

Source: Prometheus Biosciences, Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.